Abstract
This short chapter describes a heterogeneous group of industrial substances that share the ability to produce generalized CNS depression and signs of confusion through disturbances in physiological functioning within neurons.1–4 Although labeled as glues, solvents, and aerosols in prior editions of this text, in deference to the DSM-IV system, this update uses the more generic term of inhalants,5 reflecting the ability of these substances to be administered through inhalation via the lungs. Some other drugs are also inhaled, including tobacco and several agents discussed with the hallucinogens (e. g., amyl and butyl nitrite and nitrous oxide), but the clinical and biological effects of these other drugs make it more appropriate that they be discussed in chapters 8 and 12.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Crowley, T. J. Inhalant-related disorders. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry (6th ed.). Baltimore, MD: Williams & Wilkins, 1995, pp. 838–842.
Klaassen, C. D. Nonmetallic environmental toxicants. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 1673–1684.
Sharp, C. W., & Rosenberg, N. L. Inhalants. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 246–264.
Giannini, A. J. The volatile agents. In N. S. Miller (Ed.), Comprehensive handbook of drug and alcohol addiction. New York: Marcel Dekker, 1991, pp. 125–130.
American Psychiatric Association. The diagnostic and statistical manual of mental diseases (4th ed.). Washington, DC: American Psychiatric Press, 1994.
Dinwiddie, S. The pharmacology of inhalants. In A. W. Graham, T. K. Schultz, & B. B. Wilford (Eds.), Principles of addiction medicine (2nd ed.). Chevy Chase, MD: American Society of Addiction Medicine, 1998, pp. 187–193.
Balster, R. L., Bowen, S. E., Evans, E. B., & Tokarz, M. E. Evaluation of the acute behavioral effects and abuse potential of a C8-C9 isoparaffin solvent. Drug and Alcohol Dependence 46:125–135, 1997.
Richardson, H. Volatile substance abuse: Evaluation and treatment. Human Toxicology 8:319–322, 1989.
O’Brien, C. P. Drug addiction and drug abuse. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 557–577.
Balster, R. L. Neural basis of inhalant abuse. Drug and Alcohol Dependence 51:207–214, 1998.
Riegel, A. C., & French, E. D. Acute toluene induces biphasic changes in rat spontaneous locomotor activity which are blocked by remoxipride. Pharmacology, Biochemistry and behavior 62:399–402, 1999.
Dinwiddie, S. H. Volatile substances. In H. Rommelspocher & M. Schuckit (Eds.), Bailliere’s clinical psychiatry: Drugs of abuse. London: Bailliere Tindall, 1996, pp. 501–517.
Esmail, A., Warburton, B., Bland, J. M., Anderson, H. R., & Ramsey, J. Regional variations in deaths from volatile solvent abuse in Great Britain. Addiction 97:1765–1771, 1997.
Brady, M. Heavy metal: The social meaning of petrol sniffing in Australia. Canberra: Aboriginal Studies Press, 1992.
Zebrowski, P. L., & Gregory, R. J. Inhalant use patterns among Eskimo school children in western Alaska. Journal of Addictive Diseases 15:67–77, 1996.
Howard, M. O., & Jenson, J. M. Inhalant use among antisocial youth: prevalence and correlates. Addictive Behaviors 24:59–74, 1999.
Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Household Survey on drug abuse: Population estimates 1997. Rockville, MD: U.S. Department of Health and Human Services, 1998.
Johnston, L. D., O’Malley, P. M., & Bachman, J. G. National survey results on drug use from the Monitoring the Future Study, 1975–1997, Vol. I, Secondary School Students. Rockville, MD: National Institute on Drug Abuse, U.S. Department of Health and Human Services, 1998.
Mora, M. E., Villatoro, J., & Rojas, E. Drug use among students in Mexico’s northern border states. In Department of Health and Human Services, Epidemiologic trends in drug abuse. Washington, DC: U.S. Government Printing Office, 1996, pp. 367–375.
Royo-Bordonada, M. A., Cid-Ruzafa, J., Martin-Morena, J. M., & Guallar, E. Drug and alcohol use in Spain: Consumption habits, attitudes and opinions. Public Health 111:277–284, 1997.
Howard, M. O., Walker, R. D., Silk Walker, P., et al. Inhalant use among urban Anerican Indian youth. Addiction 94:83–95, 1999.
Forster, L. M., Tannhauser, M., & Barros, H. M. Drug use among street children in southern Brazil. Drug and Alcohol Dependence 43:57–62, 1996.
Lerner, R., & Ferrando, D. Inhalants in Peru. NIDA Research Monograph 148:191–204, 1995.
Mackesy-Amiti, M. E., & Fendrich, M. Inhalant use and delinquent behavior among adolescents: a comparison of inhalant users and other drug users. Addiction 94:555–564, 1999.
Taylor, J. C., Norman, C. L., Bland, J. M., Ramsey, J. D., & Anderson, A. R. Trends in deaths associated with abuse of volatile substances 1971–1995. (10th annual report) London: St George’s Hospital, 1997.
Bowen, S. E., Daniel, J., & Balster, R. L. Deaths associatd with inhalant abuse in Virginia from 1987 to 1996. Drug and Alcohol Dependence 53:239–245, 1999.
Spiller, H. A., & Krenzelok, E. P. Epidemiology of inhalant abuse reported to two regional poison centers. Journal of Toxicology 35:167–173, 1997.
Johns, A. Volatile solvent abuse and 963 deaths. British Journal of Addiction 86:1053–1056, 1991.
Miyashita, H., Saito, T., Sasaki, et al. A case of volatile solvents psychosis accompanied with multiple neurological and psychological symptoms. Japanese Journal of Alcohol and Drug Dependence 31:146–154, 1996.
Hernandez-Avila, C. A., Ortega-Soto, H. A., Jasso, A., et al. Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol. Psychiatric Services 49:812–815, 1998.
Chadwick, O., Anderson, R., Bland, M., & Ramsey, J. Neuropsychological consequences of volatile substance abuse: A population-based study of secondary school pupils. British Medical Journal 298:1679–1684, 1989.
Yamanouchi, N., Okada, S., Kodama, K., et al. Effects of MRI abnormalities on WAIS-R performance in solvent abusers. Acta Neurologica Scandinavica 96:34–39, 1997.
Yamanouchi, N., Okada, S., Kodama, K., et al. White matter changes caused by chronic solvent abuse. American Journal of Neuroradiology 16:1643–1649, 1995.
Goodwin, D. W., & Guze, S. B., Psychiatric diagnosis (5th ed.). New York: Oxford University Press, 1996.
Dinwiddie, S. H., Reich, T., & Cloninger, C. R. Solvent use and psychiatric comorbidity. British Journal of Addiction 85:1647–1656, 1990.
Dinwiddie, S. H., Zorumski, C. F., & Rubin, E. H. Psychiatric correlates of chronic solvent abuse. Journal of Clinical Psychiatry 48:334–337, 1987.
Hersh, R. Abuse of ethyl chloride. American Journal of Psychiatry 148:270–271, 1991.
Meadows, R., & Verghese, A. Medical complications of glue sniffing. Southern Medical Journal 89:455–462, 1996.
Erramouspe, J., Galvez, R., & Fischel, D. R. Newborn renal tubular acidosis associated with prenatal maternal toluene sniffing. Journal of Psychoactive Drugs 28:201–204, 1996.
Schikler, K. N., Lane, E. E., Seitz, K., & Colins, W. M. Solvent abuse associated with pulmonary abnormalities. Advances in Alcohol and Substance Abuse 3:75–81, 1984.
Tenebein, M., de Groot, W., & Rajani, K. R. Peripheral neuropathy following intentional inhalation of naphtha fumes. Canadian Medical Association Journal 131:1077–1079, 1984.
Gospe, S. M., Jr., Zhou, S. S. Toluene abuse embryopathy: longitudinal neurodevelopmental effects of prenatal exposure to toluene in rats. Reproductive Toxicology 12:119–126, 1998.
Jones, H. E., & Balster, R. L. Inhalant abuse in pregnancy. Obstetrics and Gynecology Clinics of North America 25:153–167, 1998.
Schwartz, B. S., Ford, D. P., Bolla, K. L., et al. Solvent-associated olfactory dysfunction: Not a predictor of deficits in learning and memory. American Journal of Psychiatry 148:751–756, 1991.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schuckit, M.A. (2000). Glues, Inhalants, and Aerosols. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3232-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3232-0_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-3234-4
Online ISBN: 978-1-4757-3232-0
eBook Packages: Springer Book Archive